Allegion(US:ALLE)2025-10-23 13:02Financial Data and Key Metrics Changes - Q3 revenue exceeded $1 billion, marking a 10.7% increase compared to 2024, with organic revenue growth of 5.9% driven by favorable pricing and volume [8][9] - Adjusted EPS for Q3 was $2.30, an increase of $0.14 or 6.5% year-over-year [9] - Year-to-date available cash flow reached $485.2 million, up 25.1% from the previous year [12][13] Business Line Data and Key Metrics Changes - Americas segment revenue was $844 million, up 7.9% reported and 6.4% organically, with non-residential business demand remaining healthy [9][10] - International segment revenue was $226 million, up 22.5% reported and 3.6% organically, with acquisitions contributing 13.6% to segment revenue [11] Market Data and Key Metrics Changes - Non-residential markets in the Americas are resilient, while residential markets remain soft, consistent with year-to-date growth rates [14][15] - International markets are expected to show roughly flat organic performance, with some segments at historical troughs [14][33] Company Strategy and Development Direction - The company is focused on capital allocation for long-term shareholder benefits, raising the 2025 adjusted EPS outlook to $8.10-$8.20 [5][15] - Allegion continues to pursue accretive acquisitions, with recent acquisitions including UAP and Bressant enhancing the product portfolio [6][7] Management's Comments on Operating Environment and Future Outlook - Management noted that spec activity has accelerated in 2025, supporting organic growth in non-residential markets [22][14] - The input cost environment remains dynamic, with expectations to drive pricing to offset inflation [15][68] Other Important Information - The company remains disciplined in capital deployment, with a strong balance sheet and a net debt to adjusted EBITDA ratio of 1.8x [12][13] - Allegion continues to be a dividend-paying stock, distributing $0.51 per share in Q3 [7] Q&A Session Summary Question: Update on spec writing and key verticals - Spec activity has continued to grow in 2025, with versatile spec writers capable of addressing various market needs [22] Question: M&A pipeline and potential earnings accretion - The M&A pipeline remains strong across both reporting segments, with ongoing activity in portfolio expansion and complementary software [24] Question: Conversations with building owners regarding macro uncertainty - Non-res project activity is healthy, with private finance returning to the market, supported by positive customer backlogs [31] Question: International volume growth and momentum - International segment showed volume growth after previous declines, with electronics businesses performing well [33] Question: Adjusted operating margins and corporate costs - Expectation of margin expansion in Q4, with corporate costs remaining consistent with previous quarters [36] Question: Pricing power and customer weakness - No signs of pricing fatigue observed, with the demand environment in non-res being healthy [68]